Apollo Pharmacy aims to expand its private label business in next 3 years

Company officials said the private label business was 6.5 per cent of revenue last year and expected to be 7 per cent this year

Apollo Pharmacy, a standalone business of Apollo Hospitals Group, aims to expand its private label business from the current 7 per cent of revenue to 10 per cent over the next two to three years.

The proposal being considered is to restructure the pharmacy business by segregating the front-end into a separate company, Apollo Pharmacies (APL). The necessary approvals are expected by November, with the changes to take effect from the coming April.

The focus on private labels it has now, including fast-moving consumer goods and over-the-counter products, will help grow this segment to 10 per cent of the top line and